Insider Sell Jason Clemens Sells 35,000 Shares of AdaptHealth Corp
AHCO Stock | USD 10.34 0.66 6.00% |
About 61% of Adapthealth Corp's investor base is looking to short. The analysis of overall sentiment of trading Adapthealth Corp stock suggests that many investors are alarmed at this time. Adapthealth Corp's investing sentiment overview a quick insight into current market opportunities from investing in Adapthealth Corp. Many technical investors use Adapthealth Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adapthealth |
On December 10, 2024, Jason Clemens, the Chief Financial Officer of AdaptHealth Corp , executed a sale of 35,000 shares of the company, as reported in a S
Read at gurufocus.com
![]() |
Adapthealth Corp Fundamental Analysis
We analyze Adapthealth Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adapthealth Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adapthealth Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Adapthealth Corp is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Adapthealth Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adapthealth Corp stock to make a market-neutral strategy. Peer analysis of Adapthealth Corp could also be used in its relative valuation, which is a method of valuing Adapthealth Corp by comparing valuation metrics with similar companies.
Peers
Adapthealth Corp Related Equities
LUNG | Pulmonx Corp | 4.58 | ||||
NPCE | Neuropace | 0.93 | ||||
LIVN | LivaNova PLC | 0.22 | ||||
OFIX | Orthofix Medical | 0.18 | ||||
FNA | Paragon 28 | 0.08 | ||||
ELMD | Electromed | 0.50 | ||||
AVNS | Avanos Medical | 0.73 | ||||
AORT | Artivion | 1.10 | ||||
KIDS | Orthopediatrics Corp | 1.12 | ||||
SRDX | SurModics | 1.49 | ||||
SGHT | Sight Sciences | 1.59 | ||||
ITGR | Integer Holdings | 1.65 | ||||
ANIK | Anika Therapeutics | 1.98 | ||||
AXGN | Axogen | 3.47 | ||||
APYX | Apyx Medical | 9.85 |
Check out Adapthealth Corp Hype Analysis, Adapthealth Corp Correlation and Adapthealth Corp Performance. To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adapthealth Corp. If investors know Adapthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adapthealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adapthealth Corp is measured differently than its book value, which is the value of Adapthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Adapthealth Corp's value that differs from its market value or its book value, called intrinsic value, which is Adapthealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adapthealth Corp's market value can be influenced by many factors that don't directly affect Adapthealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adapthealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adapthealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adapthealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.